[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.12.79. Please contact the publisher to request reinstatement.
[Skip to Content Landing]

Year

Day

January 16, 2020
Original Investigation

Accuracy of The Cancer Genome Atlas Classification vs American Joint Committee on Cancer Classification for Prediction of Metastasis in Patients With Uveal Melanoma

Abstract Full Text
JAMA Ophthalmol. Published online January 16, 2020. doi:10.1001/jamaophthalmol.2019.5710

This cohort study compares the accuracy of The Cancer Genome Atlas classification with the American Joint Committee on Cancer classification for predicting uveal melanoma–related metastasis.

Brief Report

Vascularization and Reperfusion of Autologous Retinal Transplant for Giant Macular Holes

Abstract Full Text
JAMA Ophthalmol. Published online January 16, 2020. doi:10.1001/jamaophthalmol.2019.5733

This case series examines vascularization and reperfusion of autologous retinal graft after transplant for giant macular holes demonstrated by multimodal imaging.

JAMA Ophthalmology Clinical Challenge

Anterior Optic Neuropathy in a Patient With Cyclical Fevers

Abstract Full Text
has active quiz
JAMA Ophthalmol. Published online January 16, 2020. doi:10.1001/jamaophthalmol.2019.4987

A 41-year-old man presented for evaluation of 2 weeks of blurred vision and pain in the left eye. What would you do next?

January 9, 2020
Original Investigation

Efficacy of a Treat-and-Extend Regimen With Ranibizumab in Patients With Neovascular Age-Related Macular Disease: A Randomized Clinical Trial

Abstract Full Text
open access
JAMA Ophthalmol. Published online January 9, 2020. doi:10.1001/jamaophthalmol.2019.5540

This noninferiority randomized clinical trial evaluates once-monthly vs a treat-and-extend regimen of ranibizumab injections in patients with age-related neovascular macular degeneration.

Cost-effectiveness of Intravitreal Ranibizumab With Verteporfin Photodynamic Therapy Compared With Ranibizumab Monotherapy for Patients With Polypoidal Choroidal Vasculopathy

Abstract Full Text
JAMA Ophthalmol. Published online January 9, 2020. doi:10.1001/jamaophthalmol.2019.5628

This economic evaluation assesses the incremental cost-effectiveness of combination intravitreal ranibizumab and verteporfin photodynamic therapy compared with ranibizumab monotherapy in patients with polypoidal choroidal vasculopathy.

JAMA Ophthalmology Clinical Challenge

Corneal Deposits in a Patient With Anti–Interferon-γ Autoantibody Syndrome

Abstract Full Text
JAMA Ophthalmol. Published online January 9, 2020. doi:10.1001/jamaophthalmol.2019.4925

A woman in her 30s was referred for corneal opacities. Her medical history was notable for keratoconjunctivitis sicca, Hashimoto thyroiditis, and anti–interferon-γ autoantibody syndrome. She had previously been diagnosed with Mycobacterium avium complex infection. On examination, she had no visual concerns. Her visual acuity was 20/20 OU. What is your diagnosis?

January 2, 2020
Original Investigation

Association of Partial Chromosome 3 Deletion in Uveal Melanomas With Metastasis-Free Survival

Abstract Full Text
JAMA Ophthalmol. Published online January 2, 2020. doi:10.1001/jamaophthalmol.2019.5403

This cohort study of patients with uveal melanomas with and without partial loss of chromosome 3 examines the association of partial chromosome 3 deletion in uveal melanomas with metastasis-free survival.

Characterization of Central Visual Field Loss in End-stage Glaucoma by Unsupervised Artificial Intelligence

Abstract Full Text
JAMA Ophthalmol. Published online January 2, 2020. doi:10.1001/jamaophthalmol.2019.5413

This cohort study provides a quantitative characterization and classification of central visual field loss among patients with end-stage glaucoma.

Invited Commentary

Importance of Partial Losses of Chromosome 3 in Uveal Melanoma in the BAP1 Gene Region

Abstract Full Text
JAMA Ophthalmol. Published online January 2, 2020. doi:10.1001/jamaophthalmol.2019.5491

Central Visual Field Loss in End-stage Glaucoma

Abstract Full Text
JAMA Ophthalmol. Published online January 2, 2020. doi:10.1001/jamaophthalmol.2019.5494
×